Aug. 6, 2013
Shareholder rights law
firm Robbins Arroyo LLP is investigating whether certain officers and directors of CareFusion Corporation (NYSE: CFN) breached their fiduciary duties to shareholders. CareFusion provides healthcare products and services in
the United States
Robbins Arroyo Investigates Claims of Improper Marketing of ChloraPrep
Robbins Arroyo is investigating claims that company officials improperly marketed CareFusion's skin preparation product, ChloraPrep. Specifically, in 2011 the company received subpoenas from the U.S. Department of Justice ("DOJ") and the U.S. Department of Health and Human Services, and in
the company received a third subpoena from the DOJ. All three subpoenas requested documents and other materials related to the sales and marketing practices for ChloraPrep and information regarding the company's relationships with healthcare professionals. On
April 25, 2013
, CareFusion announced that it had reached an agreement in principle to resolve three previously disclosed government investigations and will pay
to avoid prosecution and resolve investigations.
Robbins Arroyo highlights that CareFusion shareholders have the option to pursue a
shareholder derivative action
through which shareholders aim to hold insider wrongdoers accountable for their actions, prevent future misconduct, and bring long-term value back to the company. Concerned shareholders who would like more information about their rights and potential remedies can contact attorney
Darnell R. Donahue
at (800) 350-6003,
, or via the
shareholder information form
on the firm's website.
Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than
of value for themselves and the companies in which they have invested. For more information, please go to
Press release link:
Attorney Advertising. Past results do not guarantee a similar outcome.